New validated diagnostic criteria for pyoderma gangrenosum - 14/03/19
Doi : 10.1016/j.jaad.2018.08.068
Emanual Maverakis, MD a, ⁎ 
, Stephanie T. Le, MD a, Jeffrey Callen, MD b, Uwe Wollina, MD c, Angelo Valerio Marzano, MD d, Daniel Wallach, MD e, Courtney Schadt, MD b, Yocasta C. Martinez-Alvarado, MD f, Michelle Y. Cheng, MD a, Chelsea Ma, MD a, Alexander Merleev, PhD a, Anthony Ormerod, MD g, Fiona Craig, MRCP g, Finja Jockenhofer, MD h, Joachim Dissemond, MD h, Katrin Salva, MD h, Hywel C. Williams, DSc i, David Fiorentino, MD, PhD j, k
, Stephanie T. Le, MD a, Jeffrey Callen, MD b, Uwe Wollina, MD c, Angelo Valerio Marzano, MD d, Daniel Wallach, MD e, Courtney Schadt, MD b, Yocasta C. Martinez-Alvarado, MD f, Michelle Y. Cheng, MD a, Chelsea Ma, MD a, Alexander Merleev, PhD a, Anthony Ormerod, MD g, Fiona Craig, MRCP g, Finja Jockenhofer, MD h, Joachim Dissemond, MD h, Katrin Salva, MD h, Hywel C. Williams, DSc i, David Fiorentino, MD, PhD j, k a Department of Dermatology, University of California, Davis, Sacramento, California
b Division of Dermatology, Department of Medicine, University of Louisville, Louisville, Kentucky
c Department of Dermatology and Allergology, Academic Teaching Hospital Dresden, Dresden, Germany
d UOC di Dermatologia, IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico, Milano–Dipartimento di Fisiopatologia Medico–Chirurgica e dei Trapianti, Università degli Studi di Milano, Milano, Italy
e Department of Dermatology, Paris Hospitals, Paris, France
f Department of Dermatology, Hospital Civil de Guadalajara, Fray Antonio Alcalde, University of Guadalajara, Jalisco, Mexico
g Department of Dermatology, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, United Kingdom
h Department of Dermatology, Venereology and Allergology, University Hospital of Essen, Germany
i Centre of Evidence Based Dermatology, King's Meadow Campus, University of Nottingham, United Kingdom
j Department of Dermatology, Division of Immunology and Rheumatology, Stanford University, Stanford, California
k Department of Internal Medicine, Division of Immunology and Rheumatology, Stanford University, Stanford, California
∗Correspondence to: Emanual Maverakis, MD, Department of Dermatology, University of California, Davis, 3301 C St, Ste 1400, Sacramento, CA 95816Department of DermatologyUniversity of CaliforniaDavis3301 C StSte 1400SacramentoCA95816
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| Reprints not available from the authors. |
© 2019
Publié par Elsevier Masson SAS.
Vol 80 - N° 4
P. e87-e88 - avril 2019 Retour au numéro
Article précédent
- Reply to: “Comment on ‘Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up’”
- Laura Miguel-Gómez, David Saceda-Corralo, Sergio Vañó-Galván
- Reply to: “New validated diagnostic criteria for pyoderma gangrenosum”
- Hovik J. Ashchyan, Caroline A. Nelson, Sasha Stephen, William D. James, Robert G. Micheletti, Misha Rosenbach
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?